Browse All

Current Filters

CLEAR FILTER x

TITLE

Association of the Amount of Fibroglandular Tissue on MRI and Background Parenchymal Enhancement on DCE-MRI with Breast Cancer Risk

Differentiation of Benign from Malignant Non-Mass-Like-Enhancement in BRCA 1 Mutation Carriers Using Quantitative Kinetic Analysis

Discrimination of Renal Cell Carcinoma Subtypes with Dynamic Contrast-Enhanced Perfusion MRI and Pharmacokinetic Modeling

Peak Enhancement and Time to Peak Enhancement May Differentiate Mammographically and Sonographically Occult Breast Malignancies from Normal Enhancing Breast Parenchyma

Peak Enhancement of Up to 1.0cm Breast Masses May Help Differentiate Cancers from Benign Entities